Related Experiment Video
Updated: Jun 27, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Atherosclerosis in hemodialysis patients--the role of microinflammation
Sebastjan Bevc1, Samir Sabic, Radovan Hojs
1Clinic for Internal Medicine, Department of Dialysis, University Medical Center Maribor, Maribor, Slovenia. sebastjanb@yahoo.com
Insights
Cardiovascular disease risk in hemodialysis patients is linked to inflammation. Atherosclerosis in these patients correlates with inflammatory markers like interleukin 2 receptor and VCAM-1, suggesting non-traditional risk factors.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of death in end-stage renal disease (ESRD) patients.
- Hemodialysis (HD) patients exhibit a higher risk for coronary heart disease than the general population.
- Traditional risk factors do not fully explain the elevated CVD risk in HD patients.
Purpose of the Study:
- To investigate correlations between asymptomatic atherosclerosis and inflammatory markers in HD patients.
- To assess specific inflammatory markers including hsCRP, IL-6, TNF-alpha, IL-2R, ICAM-1, and VCAM-1.
- To identify potential non-traditional risk factors for CVD in HD patients.
Main Methods:
- Ninety-five HD patients (56% male, mean age 60 years) were included.
- B-mode ultrasonography measured intima-media thickness (IMT) and plaque occurrence in carotid arteries.
- Serum concentrations of inflammatory markers were determined from blood samples.
Main Results:
- Mean IMT was 0.83 mm; 84% of patients had plaques.
- Significant correlations were found between IMT and IL-2R (r=0.269, p<0.022) and VCAM-1 (r=0.290, p<0.014).
- Multiple linear regression analysis indicated a relationship between IMT and IL-2R (p=0.049). No association was found between inflammatory markers and plaques.
Conclusions:
- Atherosclerosis in HD patients is associated with specific inflammatory markers.
- Interleukin 2 receptor (IL-2R) and VCAM-1 are identified as potential nontraditional risk factors for atherosclerosis in this population.
- Inflammation plays a role in the development of atherosclerosis in hemodialysis patients.
Introduction:
Cardiovascular diseases (CVDs) are the most frequent cause of morbidity and mortality in patients with end-stage renal disease, and the risk for coronary heart disease is higher among the hemodialysis (HD) patients than in the general population. This excess risk for coronary heart disease is not entirely explained by traditional risk factors for CVDs. The aim of the study was to determine possible correlations between asymptomatic atherosclerosis and inflammatory markers (high sensitivity CRP [hsCRP], interleukin 6 [IL-6], tumor necrosis factor-alpha [TNF-alpha], interleukin 2 receptor [IL-2R], and selective adhesion molecules ICAM-1 and VCAM-1) in HD patients.
Patients And Methods:
In our study, 95 HD patients, 56 (59%) male and 39 (41%) female, were included. The mean age was 60 +/- 13 years, ranging from 22-81 years. Using B-mode ultrasonography (US), we measured intima-media thickness (IMT) and plaque occurrence (markers of asymptomatic atherosclerosis) in carotid arteries in these patients. In the 1-4 weeks after US examination, we took blood samples from patients to determine serum concentrations of inflammatory markers.
Results:
The mean IMT value was 0.83 +/- 0.21 mm, ranging from 0.5 to 2 mm. The plaques were found in 63 (84%) of HD patients. Correlations between IMT values and serum concentrations of IL-2R (r = 0.269; p < 0.022) and VCAM-1 (r = 0.290; p < 0.014) were found. Multiple linear regression analysis showed relationship between IMT values and IL-2R (p = 0.049). No relationship between inflammatory markers and plaques was found.
Conclusion:
The results indicate that atherosclerosis in HD patients correlates with some nontraditional risk factors--the markers of inflammation.
Related Concept Videos
Atherosclerosis I: Introduction
Hemodialysis I: Introduction
Inflammation
Peripheral Artery Disease I: Introduction
Diabetic Nephropathy
Chronic Kidney Disease II: Clinical Manifestations